Doshi Dipal

CIK 00016130843 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001613084

Recent Transactions

50 trades

Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2026-03-03$11.76/sh−19,181→ 526,014 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2026-03-02$11.66/sh−9,869→ 545,195 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2026-03-01+208,000→ 208,000 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2026-03-01+139,400→ 555,064 total
Award
Azenta, Inc.$AZTA
Common
2026-02-05$27.85/sh+5,663→ 9,703 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-09-02$5.43/sh−8,723→ 415,664 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-03$11.68/sh−17,566→ 424,387 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2025-03-01+173,400→ 173,400 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-01+116,200→ 441,953 total
Award
Azenta, Inc.$AZTA
Common
2025-02-07$52.32/sh+4,040→ 4,040 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-05$15.13/sh−826→ 325,753 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-04$15.42/sh−4,744→ 326,579 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$15.76/sh−2,328→ 332,147 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$17.70/sh−72→ 331,323 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$16.93/sh−752→ 331,395 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-07-15$17.81/sh−1,600→ 334,475 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-07-12$18.00/sh−300→ 336,075 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-06-13$16.17/sh−1,000→ 336,375 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-05-17$15.11/sh−1,200→ 337,375 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-05-16$15.00/sh−1,800→ 338,575 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-05$12.28/sh−5,049→ 340,375 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-04$13.37/sh−1,391→ 345,424 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-04$12.42/sh−1,164→ 346,815 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-03-01+158,500→ 158,500 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-01+104,700→ 347,979 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-02-15$15.00/sh−1,000→ 243,279 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-01-16$15.99/sh−1,000→ 244,279 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-12-20$15.00/sh−1,000→ 245,279 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-11-13$16.23/sh−1,000→ 246,279 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-10-17$15.00/sh−1,000→ 247,279 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-13$15.00/sh−1,000→ 248,279 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-05$14.46/sh−1,440→ 249,279 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-01+49,650→ 250,719 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-09-01+75,250→ 75,250 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-14$15.67/sh−1,000→ 201,069 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-04-27$13.71/sh−2,000→ 202,069 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-04-17$18.01/sh−2,092→ 204,069 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-27$14.63/sh−1,800→ 256,011 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-27$15.51/sh−200→ 255,811 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-02$11.60/sh−3,324→ 257,811 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-01+99,300→ 261,135 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-03-01+150,500→ 150,500 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-03-01+75,250→ 75,250 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-01+49,650→ 206,161 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-02-28$12.00/sh−2,000→ 161,835 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-01-27$12.00/sh−2,000→ 163,835 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-01-09$15.02/sh−2,410→ 165,835 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-12-29$15.01/sh−400→ 168,245 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-12-28$15.01/sh−4,521→ 168,645 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-12-27$15.04/sh−9,069→ 173,166 total

Companies

Recent Filings

Address

C/O ENTRADA THERAPEUTICS, INC. ONE DESIGN CENTER PLACE, SUITE 17-500

BOSTON, MA, 02210

View on SEC.gov